PhenomeX (PhenomeX) ROCE % : -99.81% (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is PhenomeX ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. PhenomeX's annualized ROCE % for the quarter that ended in Jun. 2023 was -99.81%.

PhenomeX ROCE % Historical Data

The historical data trend for PhenomeX's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhenomeX ROCE % Chart

PhenomeX Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

-17.78

-14.97

-21.22

-26.89

-44.60

PhenomeX Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
ROCE %	Get a 7-Day Free Trial														-44.60	-40.59	-60.91	-42.45	-99.81

PhenomeX ROCE % Calculation

PhenomeX's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-97.03	/	( ( (287.253 - 32.751)	+	(226.094 - 45.49) )	/ 2 )
	=	-97.03	/	( (254.502	+	180.604)	/ 2 )
	=	-97.03	/	217.553
	=	-44.60 %

PhenomeX's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Mar. 2023 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Mar. 2023 )		(Q: Jun. 2023 )
	=	-194.248	/	( ( (300.561 - 47.442)	+	(178.332 - 42.225) )	/ 2 )
	=	-194.248	/	( ( 253.119	+	136.107 )	/ 2 )
	=	-194.248	/	194.613
	=	-99.81 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

PhenomeX (NAS:CELL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

PhenomeX ROCE % Related Terms

Thank you for viewing the detailed overview of PhenomeX's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

PhenomeX (PhenomeX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PhenomeX Inc (NAS:CELL) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5858 Horton Street, Suite 320, Emeryville, CA, USA, 94608

Website

https://www.phenomex.com

PhenomeX Inc is a functional cell biology company that provides live cell biology research tools which deliver deep insights into cellular function and new perspectives on phenomes.

Executives

Siddhartha Kadia	director, officer: Chief Executive Officer	7475 LUSK BOULEVARD, SAN DIEGO CA 92121
Mehul Joshi	officer: Chief Financial Officer	C/O BERKELEY LIGHTS, INC., 5858 HORTON STREET, SUITE 320, EMERYVILLE CA 94608
Peter Silvester	director	C/O BERKELEY LIGHTS, INC., 5858 HORTON STREET, SUITE 320, EMERYVILLE CA 94608
John R Chiminski	director	C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Jessica Hopfield	director	C/O 600 TECHNOLOGY PARK DRIVE, SUITE 200, BILLERICA MA 01821
Bird Mergersub Corp	10 percent owner	40 MANNING ROAD, BILLERICA MA 01821
Bruker Corp	10 percent owner	40 MANNING RD, BILLERICA MA 01821
James Paul Mcclaskey	officer: SVP, Chief Accounting Officer	C/O BERKELEY LIGHTS, INC., C/O BERKELEY LIGHTS, INC., EMERYVILLE CA 94608
Scott David Chaplin	officer: Chief Legal Officer	3101 WILSON BOULEVARD, SUITE 700, ARLINGTON VA 22201
Eric Hobbs	director, officer: Chief Executive Officer	C/O BERKELEY LIGHTS, INC., 5858 HORTON STREET, SUITE 320, EMERYVILLE CA 94608
James Rothman	director	135 EAST 83RD STREET, APT. 15C, NEW YORK NY 10028
Gregory T Lucier	director	C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Keith Breinlinger	officer: Chief Technical Officer	C/O BERKELEY LIGHTS, INC., 5858 HORTON STREET, SUITE 320, EMERYVILLE CA 94608
Igor Y Khandros	director, 10 percent owner	25 HACIENDAS ROAD, ORINDA CA 94563
Stuart L Merkadeau	officer: General Counsel	7005 SOUTHFRONT ROAD, LIVERMORE CA 94551